A webinar on recent advances in the treatment and control of methicillin-resistant staphylococci, focusing on methicillin-resistant S. pseudintermedius (MRSP), which can often be much more resistant than MRSA.
The Bella Moss Foundation is to present a CPD webinar on methicillin-resistant S. pseudintermedius (MRSP) in conjunction with the Webinar Vet.
While MRSA often attracts the most attention, MRSP has emerged at an astounding rate and is now a very important animal health risk. This multidrug resistant bacterium has increased dramatically internationally, particularly as a cause of skin, ear and surgical site infections.
Often much more resistant than MRSA, some MRSP infections (especially orthopedic surgery-associated infections) can be very difficult, leading to longterm, expensive, often frustrating and sometimes futile treatment courses.
MRSP poses a clear and significant risk to the pet population, similar to the situation with MRSA in humans, and highlights the need for careful attention to patient management, antimicrobial use, infection control and disease surveillance, to try to limit its impact.
|Date: December 8, 2011 (21.00 GMT)
Subject: Recent advances in the treatment and control of methicillin-resistant staphylococci
Presented by: J Scott Weese DVM DVSc DipACVIM
All funds received from sales of this webinar will go directly to the Bella Moss Foundation to help with educational projects for vets and nurses. The charity would like to express gratitude to Dr Scott Weese and Webinar Vet for helping us make this possible.